Osnat Bairey
0000-0002-8576-7686
Publication & Citation Trends
Publications
0 total
Real-world efficacy and safety of venetoclax-based therapy in israeli patients with CLL/SLL: Results from the reveal study
Cited by 0
Semantic Scholar
Phase II Prospective Trial of Fixed Duration Obinutuzumab, Ibrutinib and, Venetoclax in an Elderly Cohort of Patients with Richter's Syndrome-Givers Regimen
Cited by 1
Semantic Scholar
Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35) OA
Cited by 4
Semantic Scholar
P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA OA
Cited by 0
Semantic Scholar
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma
Cited by 14
Semantic Scholar
P11.67.B A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - OUTCOMES INDICATIVE OF IMPROVED SURVIVAL OVER TIME
Cited by 0
Semantic Scholar
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Cited by 4
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(95)
Chronic Lymphocytic Leukemia Research
(90)
CNS Lymphoma Diagnosis and Treatment
(32)
Immunodeficiency and Autoimmune Disorders
(21)
Chronic Myeloid Leukemia Treatments
(12)
Affiliations
Tel Aviv University
Kaplan Medical Center
Rabin Medical Center
Shaare Zedek Medical Center
Hadassah Academic College